ArticleScientific data2026
How can biological databases support the new UN mechanism for benefit-sharing from digital sequence information?
Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
Abstract
In October 2024, Parties to the United Nations Convention on Biological Diversity agreed to a new multilateral mechanism to fund biodiversity conservation through the sharing of benefits from open biodiversity data. Biological databases hosting genetic and other biological data, known as digital sequence information (DSI), are central to the implementation of the mechanism. This paper assesses the new international agreement and its implications for DSI databases. We walk through the database provisions in COP16 Decision 16/2, which include notifying users and submitters about the mechanism, improving metadata on geographical location of sample collection, and consistency with open access, as well as consideration of the FAIR, CARE, and TRUST principles. Drawing on surveys, interviews, and a workshop with biological database managers, we identify practical and scalable measures including updating terms of use, revising submission procedures, and strengthening user communication. We also propose approaches to capture and report non-monetary benefits such as capacity building, publications, interoperability, and training. These actions illustrate how DSI databases can remain open, sustainable, and globally connected while supporting benefit-sharing from the use of DSI on genetic resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.